GlassScriptPhysician profile
Elizabeth K Rodriguez
NPI 1083439228
$1,293.28
in general payments reported to CMS, 2019-2025
19 companies · $1,274 in 2025
The $1,274 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $19.44 · 2025: $1,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $364.61 | 2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $133.08 | 2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $95.02 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $83.11 | 2025 | Trintellix |
| Ardelyx, INC. | $77.90 | 2025 | Ibsrela |
| Glaxosmithkline, LLC. | $75.44 | 2025 | Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $61.67 | 2025 | Gemtesa |
| Dexcom, INC. | $61.56 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $52.73 | 2025 | Verquvo |
| Scpharmaceuticals INC. | $51.98 | 2025 | |
| Axsome Therapeutics, INC. | $44.56 | 2025 | Auvelity |
| Esperion Therapeutics, INC. | $43.33 | 2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $35.82 | 2025 | Farxiga, Breztri |
| Abbvie INC. | $31.61 | 2025 | |
| Daxor Corporation | $19.44 | 2024 | Bva-100 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.58 | 2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $15.32 | 2025 | Zoryve |
| Shield Therapeutics INC | $14.99 | 2025 | |
| Amgen INC. | $14.53 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.